Last reviewed · How we verify
NCT02775045: EoE
Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis
trial testing Observation Period in Eosinophilic Esophagitis in 28 participants. Completed in 13 December 2018.
13 December 2018
Quick facts
| Lead sponsor | University of Wisconsin, Madison |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 28 |
| Start date | 30 August 2016 |
| Primary completion | 13 December 2018 |
| Estimated completion | 13 December 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Observation Period
Conditions studied
- Eosinophilic Esophagitis — all drugs for Eosinophilic Esophagitis →
Sponsor
University of Wisconsin, Madison
Who can join
18 and older, any sex, with Eosinophilic Esophagitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to improve the overall management of patients with Eosinophil Esophagitis. Currently, the best way to monitor Eosinophil Esophagitis is repeating the endoscopy procedure. The investigators plan to identify a biomarker in the blood (a measurable substance) that tracks with disease activity and will reduce the need for follow-up endoscopies.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Platelet association with leukocytes in active eosinophilic esophagitis.
Bartig KA, Lee KE, Mosher DF, Mathur SK, et al · · 2021 · cited 3× · PMID 33891621 · DOI 10.1371/journal.pone.0250521
Verify or expand the search:
- PubMed search for NCT02775045
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Eosinophilic Esophagitis
Currently open trials in the same condition.
- NCT07027826 — The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in · NA · recruiting
- NCT07227506 — Utility of Mucosal Impedance Device in Chronic Esophageal Disorders: · recruiting
- NCT06972147 — Prevalence and Description of FIRE (Food Induced Immediate Response of the Esophagus) in the Pediatric Population With E · recruiting
- NCT06695897 — A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patie · recruiting
- NCT06443346 — Prospective Registry of EoSinophilic esOphagitis · recruiting
Other University of Wisconsin, Madison trials
Trials by the same sponsor.
- NCT07440004 — Testing a Digital Mindfulness Program to Support People Experiencing Suicidal Thoughts · Phase 1 · recruiting
- NCT07278466 — The COMParing App Support Strategies Study · NA · recruiting
- NCT07475104 — Redesigning Surgical Care for Patients in Wisconsin · NA · enrolling by invitation
- NCT07470723 — The ORIGIN-FH Study · NA · recruiting
- NCT06975657 — Well-being Skills for Reentry · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02775045 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Wisconsin, Madison
- Last refreshed: 30 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02775045.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing